Mechanisms of cytotoxicity used by human peripheral blood T-cell subsets.
Smyth
M J
MJ
Cellular Cytotoxicity Laboratory, Austin Research Institute, Heidelberg, Victoria, Australia.
D003994:Bucladesine / Q000494:pharmacology; D015704:CD4 Antigens / Q000276:immunology; D016827:CD8 Antigens / Q000276:immunology; D002772:Cholera Toxin / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic; D003609:Dactinomycin / Q000494:pharmacology; D004533:Egtazic Acid / Q000494:pharmacology; D004640:Emetine / Q000494:pharmacology; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D016685:Mitomycin / Q000494:pharmacology; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000502:physiology
D015704:CD4 Antigens; D016827:CD8 Antigens; D014409:Tumor Necrosis Factor-alpha; D003609:Dactinomycin; D016685:Mitomycin; D004533:Egtazic Acid; D003994:Bucladesine; D016572:Cyclosporine; D002772:Cholera Toxin; D003513:Cycloheximide; D004640:Emetine